A61M60/191

NOVEL NANOTECHNOLOGY-DRIVEN PROTOTYPES FOR AI-ENRICHED BIOCOMPATIBLE PROSTHETICS FOLLOWING EITHER RISK OF ORGAN FAILURE OR MODERATE TO SEVERE IMPAIRMENT
20230009416 · 2023-01-12 ·

Three groups of biocompatible implants were created, to leverage physiological impairment caused by (i) cardiovascular, (ii) renal, and (iii) neuronal diseases. Each group of implants is subdivided into three categories according to extra functionality added plus integrated additions. The first generation contains basic functionality and the second and third generations contain extra functions. Finally, further additions can be combined and integrated. Therefore, the first group comprises of the “First Generation of Cardiovascular Implants” plus the “Second Generation of Cardiovascular Implants” plus the “Third Generation of Cardiovascular Implants” plus additional integrations named “Additions”. Equally, the second group comprises of the “First”, the “Second” and the “Third” Generation of Renal Prosthetics plus Additions. The same categorisation applies to Neural Implants, which are three generations plus additions. This can be found in the description of claims presented in the Austrian Prio (provisional patent application) number A 60273/2019, from 11 Dec. 2019.

NOVEL NANOTECHNOLOGY-DRIVEN PROTOTYPES FOR AI-ENRICHED BIOCOMPATIBLE PROSTHETICS FOLLOWING EITHER RISK OF ORGAN FAILURE OR MODERATE TO SEVERE IMPAIRMENT
20230009416 · 2023-01-12 ·

Three groups of biocompatible implants were created, to leverage physiological impairment caused by (i) cardiovascular, (ii) renal, and (iii) neuronal diseases. Each group of implants is subdivided into three categories according to extra functionality added plus integrated additions. The first generation contains basic functionality and the second and third generations contain extra functions. Finally, further additions can be combined and integrated. Therefore, the first group comprises of the “First Generation of Cardiovascular Implants” plus the “Second Generation of Cardiovascular Implants” plus the “Third Generation of Cardiovascular Implants” plus additional integrations named “Additions”. Equally, the second group comprises of the “First”, the “Second” and the “Third” Generation of Renal Prosthetics plus Additions. The same categorisation applies to Neural Implants, which are three generations plus additions. This can be found in the description of claims presented in the Austrian Prio (provisional patent application) number A 60273/2019, from 11 Dec. 2019.

Left Heart Assist Device and Method
20180008408 · 2018-01-11 · ·

A device, a kit and a method is presented for permanently augmenting the pump function of the left heart. The mitral valve plane is assisted in a movement along the left ventricular long axis during each heart cycle. The very close relationship between the coronary sinus and the mitral valve is used by various embodiments of a medical device providing this assisted movement. By means of catheter technique an implant is inserted into the coronary sinus, the device is augmenting the up and down movement of the mitral valve and thereby increasing the left ventricular diastolic filling when moving upwards and the piston effect of the closed mitral valve when moving downwards.

Cardiac compression device having passive and active chambers

The present invention provides methods, systems, kits, and cardiac compression devices that have both passive chambers and active chambers to improve heart function.

Cardiac Compression Device Having Passive And Active Chambers

The present invention provides methods, systems, kits, and cardiac compression devices that have both passive chambers and active chambers to improve heart function.

Cardiac Compression Device Having Passive And Active Chambers

The present invention provides methods, systems, kits, and cardiac compression devices that have both passive chambers and active chambers to improve heart function.

Left Atrial Appendage Stasis Reduction

Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.

Heart assisting device
20230069821 · 2023-03-02 ·

The present invention relates to surgical or laparoscopic method of creating and maintaining an opening in the thoracic diaphragm of a patient. In said method, an incision in the thoracic diaphragm is created, thereby creating an opening in the thoracic diaphragm. Further a diaphragm passing part is placed in said opening created in the thoracic diaphragm, passing from the abdomen, through the thoracic diaphragm at the pericardial contacting section, into the pericardium; When placing the diaphragm passing part a force transferring part of the diaphragm passing part is placed in contact with the thoracic diaphragm, the force transferring part being adapted to, by motion of the force transferring part, transfer force between the abdominal side of the thoracic diaphragm and the thoracic side of the thoracic diaphragm or the pericardium while sliding against the thoracic diaphragm.

Heart assisting device
20230069821 · 2023-03-02 ·

The present invention relates to surgical or laparoscopic method of creating and maintaining an opening in the thoracic diaphragm of a patient. In said method, an incision in the thoracic diaphragm is created, thereby creating an opening in the thoracic diaphragm. Further a diaphragm passing part is placed in said opening created in the thoracic diaphragm, passing from the abdomen, through the thoracic diaphragm at the pericardial contacting section, into the pericardium; When placing the diaphragm passing part a force transferring part of the diaphragm passing part is placed in contact with the thoracic diaphragm, the force transferring part being adapted to, by motion of the force transferring part, transfer force between the abdominal side of the thoracic diaphragm and the thoracic side of the thoracic diaphragm or the pericardium while sliding against the thoracic diaphragm.

Heart assisting device
11660430 · 2023-05-30 ·

The present invention relates to surgical or laparoscopic method of creating and maintaining an opening in the thoracic diaphragm of a patient. In said method, an incision in the thoracic diaphragm is created, thereby creating an opening in the thoracic diaphragm. Further a diaphragm passing part is placed in said opening created in the thoracic diaphragm, passing from the abdomen, through the thoracic diaphragm at the pericardial contacting section, into the pericardium; When placing the diaphragm passing part a force transferring part of the diaphragm passing part is placed in contact with the thoracic diaphragm, the force transferring part being adapted to, by motion of the force transferring part, transfer force between the abdominal side of the thoracic diaphragm and the thoracic side of the thoracic diaphragm or the pericardium while sliding against the thoracic diaphragm.